Loading
Latest filing published 20 Mar 2009 for Lev Pharmaceuticals Inc, €37.7M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of David J. Steinberg in Lev Pharmaceuticals Inc. In total, 19 filings cover trades dated from 18 March 2008 to 21 October 2008.
On the market, this insider has only ever bought: 17 purchases, €1.0M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant.
A typical purchase (the median) is worth €3,656.
Most recently, on 20 March 2009, the filings show a transaction worth €37.7M in Lev Pharmaceuticals Inc. The last purchase on record was published on 2 October 2008, which is 6,596 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations